US6770283B1
(en)
|
1990-12-13 |
2004-08-03 |
Bioption Ab |
DNA expression systems based on alphaviruses
|
SE9003978D0
(sv)
|
1990-12-13 |
1990-12-13 |
Henrik Garoff |
Dna expressionssystem baserade paa ett virus replikon
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
US7214787B1
(en)
*
|
1993-09-21 |
2007-05-08 |
United States Of America As Represented By The Secretary Of The Army |
Recombinant vaccine against botulinum neurotoxin
|
DE19503082A1
(de)
*
|
1995-02-01 |
1996-08-08 |
Univ Ludwigs Albert |
Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen
|
US5792462A
(en)
*
|
1995-05-23 |
1998-08-11 |
University Of North Carolina At Chapel Hill |
Alphavirus RNA replicon systems
|
US6458560B1
(en)
|
1996-04-05 |
2002-10-01 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
US6451592B1
(en)
*
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
US5811407A
(en)
|
1997-02-19 |
1998-09-22 |
The University Of North Carolina At Chapel Hill |
System for the in vivo delivery and expression of heterologous genes in the bone marrow
|
US6097978A
(en)
*
|
1997-07-03 |
2000-08-01 |
Medtronic Inc. |
Measurement confirmation devices and methods for fluoroscopically directed surgery
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US6348450B1
(en)
*
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
US6197502B1
(en)
*
|
1997-11-17 |
2001-03-06 |
Cytos Biotechnology Ag |
Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property
|
WO1999050432A1
(en)
|
1998-03-27 |
1999-10-07 |
Cytos Biotechnology Ag |
Inducible alphaviral gene expression system
|
ATE457176T1
(de)
|
1998-04-08 |
2010-02-15 |
Univ North Carolina |
Krebsimpfstoff enthaltend alphavirusrepliconpartikeln
|
WO2000000616A2
(en)
*
|
1998-06-29 |
2000-01-06 |
U.S. Medical Research Institute Of Infectious Diseases |
Marburg virus vaccines
|
US7736656B2
(en)
*
|
1998-06-29 |
2010-06-15 |
The United States Of America As Represented By The Secretary Of The Army |
Immunogenic compositions and vaccines for Ebola
|
US7267823B2
(en)
|
1998-06-29 |
2007-09-11 |
United States Of America As Represented By The Secretary Of The Army |
Ebola peptides and immunogenic compositions containing same
|
AU759461B2
(en)
*
|
1998-07-10 |
2003-04-17 |
U.S. Medical Research Institute Of Infectious Diseases |
Botulinum neurotoxin vaccine
|
US6770479B1
(en)
|
1998-07-10 |
2004-08-03 |
The United States Of America As Represented By The Secretary Of The Army |
Anthrax vaccine
|
US6632640B1
(en)
*
|
1998-07-10 |
2003-10-14 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccine against Staphylococcus intoxication
|
WO2000006205A1
(en)
*
|
1998-07-29 |
2000-02-10 |
Invitrogen Corporation |
Regulated expression of recombinant proteins using rna viruses
|
IL143441A0
(en)
*
|
1998-11-30 |
2002-04-21 |
Cytos Biotechnology Ag |
Non-naturally occuring antigen arrays and processes for the preparation thereof
|
US6423544B1
(en)
|
1998-12-31 |
2002-07-23 |
Chiron Corporation |
Compositions and methods for producing recombinant virions
|
EP1141361B1
(en)
|
1998-12-31 |
2010-04-21 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for packaging of alphavirus vectors
|
US6329201B1
(en)
|
1998-12-31 |
2001-12-11 |
Chiron Corporation |
Compositions and methods for packaging of alphavirus vectors
|
EP1035205A1
(en)
*
|
1999-03-08 |
2000-09-13 |
Stichting Dienst Landbouwkundig Onderzoek |
Non-spreading pestivirus
|
US8647864B2
(en)
*
|
1999-04-14 |
2014-02-11 |
Novartis Ag |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
EP1175497B1
(en)
*
|
1999-04-14 |
2010-04-07 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
AU1013601A
(en)
|
1999-10-22 |
2001-05-08 |
Aventis Pasteur Limited |
Method of inducing and/or enhancing an immune response to tumor antigens
|
MXPA02004148A
(es)
*
|
1999-10-26 |
2003-08-20 |
Int Aids Vaccine Initiative |
Vectores bacterianos invasivos para expresar replicones de alfavirus.
|
WO2001042442A2
(en)
|
1999-12-10 |
2001-06-14 |
Cytos Biotechnology Ag |
Activation of endogenous genes by genomic introduction of a replicon
|
CA2407050A1
(en)
*
|
2000-04-25 |
2001-11-01 |
Chiron Corporation |
Alphavirus-based vectors for persistent infection
|
EP1278542A2
(en)
|
2000-05-05 |
2003-01-29 |
Cytos Biotechnology AG |
Molecular antigen arrays and vaccines
|
CA2408328C
(en)
*
|
2000-05-10 |
2012-04-17 |
Aventis Pasteur Limited |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
DE60135983D1
(de)
|
2000-05-31 |
2008-11-13 |
Novartis Vaccines & Diagnostic |
Verfahren zur reinigung von alphaviralen replikon partikeln
|
US6783939B2
(en)
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
AU2001273313A1
(en)
*
|
2000-07-07 |
2002-01-21 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified hiv genes for use as vaccines
|
EP1301591A4
(en)
*
|
2000-07-13 |
2004-05-26 |
Invitrogen Corp |
METHOD AND COMPOSITIONS FOR QUICK PROTEIN AND PEPTIDE EXTRACTION AND INSULATION USING LYSIS MATRIZE
|
KR100366624B1
(ko)
*
|
2000-07-19 |
2003-01-09 |
삼성전자 주식회사 |
반사 방지막을 이용하는 반도체 소자 제조방법
|
DK1363938T3
(en)
*
|
2000-08-03 |
2014-03-24 |
Univ Johns Hopkins |
Molecular vaccine that connects an endoplasmic reticulum-chaperonepolypeptid with an antigen
|
US7034141B2
(en)
*
|
2000-08-29 |
2006-04-25 |
Wyeth Holdings Corporation |
Packaging of positive-strand RNA virus replicon particles
|
AU2001290642A1
(en)
*
|
2000-09-07 |
2002-03-22 |
University Of North Carolina At Chapel Hill |
Vectors derived from south african arbovirus no. 86
|
KR20030074680A
(ko)
|
2000-12-28 |
2003-09-19 |
와이어쓰 |
스트렙토코커스 뉴모니에 유래 재조합 보호 단백질
|
US7264810B2
(en)
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
US7128911B2
(en)
|
2001-01-19 |
2006-10-31 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of bone disease
|
US7094409B2
(en)
*
|
2001-01-19 |
2006-08-22 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of allergic eosinophilic diseases
|
WO2002074920A2
(en)
*
|
2001-03-16 |
2002-09-26 |
Johns Hopkins University |
A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same
|
AU2002327614B2
(en)
*
|
2001-09-06 |
2007-12-06 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
US7115266B2
(en)
*
|
2001-10-05 |
2006-10-03 |
Cytos Biotechnology Ag |
Angiotensin peptide-carrier conjugates and uses thereof
|
MXPA04002644A
(es)
|
2001-10-05 |
2004-07-08 |
Cytos Biotechnology Ag |
Conjugados que portan un peptido de angiotensina y usos de los mismos.
|
ATE467680T1
(de)
*
|
2001-10-11 |
2010-05-15 |
Merck Sharp & Dohme |
Hepatitis-c-virus-impfstoff
|
EA007905B1
(ru)
|
2001-11-16 |
2007-02-27 |
Байоджен Айдек Инк. |
Полицистронная экспрессия антител
|
US20030219459A1
(en)
*
|
2002-01-18 |
2003-11-27 |
Cytos Biotechnology Ag |
Prion protein carrier-conjugates
|
US7786278B2
(en)
|
2002-04-09 |
2010-08-31 |
Sanofi Pasteur Limited |
Modified CEA nucleic acid and expression vectors
|
US20060088909A1
(en)
*
|
2002-05-17 |
2006-04-27 |
Compans Richard W |
Virus-like particles, methods of preparation, and immunogenic compositions
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
EP1531859A4
(en)
*
|
2002-05-31 |
2005-12-07 |
Univ Jefferson |
COMPOSITIONS AND METHODS FOR TRANSEPITHELIAL MOLECULAR TRANSPORT
|
US20040005338A1
(en)
*
|
2002-06-20 |
2004-01-08 |
Cytos Biotechnology Ag |
Packaged virus-like particles for use as adjuvants: method of preparation and use
|
AU2003267971A1
(en)
*
|
2002-06-21 |
2004-01-06 |
Alphavax, Inc. |
Improved alphavirus vectors having attenuated virion structural proteins
|
US7601351B1
(en)
|
2002-06-26 |
2009-10-13 |
Human Genome Sciences, Inc. |
Antibodies against protective antigen
|
AU2003246690B2
(en)
|
2002-07-17 |
2010-03-11 |
Cytos Biotechnology Ag |
Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
|
BR0312297A
(pt)
|
2002-07-18 |
2005-04-12 |
Cytos Biotechnology Ag |
Conjugados veìculos de hapteno e seu uso
|
KR101070078B1
(ko)
|
2002-07-19 |
2011-10-04 |
노파르티스 파르마 아게 |
아밀로이드 베타1-6 항원 어레이를 포함하는 백신 조성물
|
US6875433B2
(en)
*
|
2002-08-23 |
2005-04-05 |
The United States Of America As Represented By The Secretary Of The Army |
Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
|
DK1585812T3
(en)
|
2002-12-13 |
2017-04-10 |
Alphavax Inc |
MULTI-ANTI-ANTI-ANTI-VIRUS REPLICATE PARTICLES AND PROCEDURES
|
US7078218B2
(en)
*
|
2002-12-13 |
2006-07-18 |
Alphavax, Inc. |
Alphavirus particles and methods for preparation
|
CA2518546C
(en)
*
|
2003-03-20 |
2012-11-13 |
Alphavax, Inc. |
Improved alphavirus replicons and helper constructs
|
WO2004098526A2
(en)
*
|
2003-05-05 |
2004-11-18 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
WO2004102198A2
(en)
*
|
2003-05-15 |
2004-11-25 |
Cytos Biotechnology Ag |
Selection of b cells with specificity of interest: method of preparation and use
|
US7790181B2
(en)
|
2003-05-29 |
2010-09-07 |
The United States Of America As Represented By The Secretary Of The Army |
Live attenuated viral vaccines for Eastern Equine Encephalitis virus
|
MXPA05012542A
(es)
*
|
2003-06-05 |
2006-02-08 |
Wyeth Corp |
Composiciones inmunogenicas que comprenden vectores de replicon del virus de la encefalitis equina venezolana y antigenos de la proteina del paramixovirus.
|
US20060099587A1
(en)
*
|
2003-06-20 |
2006-05-11 |
Johnston Robert E |
Alphavirus vectors having attentuated virion structural proteins
|
ATE432285T1
(de)
*
|
2003-07-11 |
2009-06-15 |
Alphavax Inc |
Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren
|
EP1660631B1
(en)
*
|
2003-08-01 |
2013-04-24 |
Life Technologies Corporation |
Compositions and methods for purifying short rna molecules
|
JP4668919B2
(ja)
*
|
2003-10-08 |
2011-04-13 |
サノフィ パストゥール インコーポレイテッド |
修飾cea/b7ベクター
|
BRPI0507002A
(pt)
*
|
2004-01-20 |
2007-06-05 |
Cytos Biotechnology Ag |
conjugados veìculos de grelina
|
AU2005222641B2
(en)
*
|
2004-03-15 |
2011-04-07 |
Nektar Therapeutics |
Polymer-based compositions and conjugates of HIV entry inhibitors
|
ES2321212T3
(es)
*
|
2004-05-18 |
2009-06-03 |
Alphavax, Inc. |
Vectores alfavirus derivados de tc-83, particulas y metodos antecentes de la invencion.
|
EP2811027A1
(en)
|
2004-05-21 |
2014-12-10 |
Novartis Vaccines and Diagnostics, Inc. |
Alphavirus vectors for RSV and PIV vaccines
|
CN1960752A
(zh)
*
|
2004-06-02 |
2007-05-09 |
赛托斯生物技术公司 |
非人类tnf-肽的载体偶联物的医药用途
|
US7862829B2
(en)
*
|
2004-07-09 |
2011-01-04 |
University Of North Carolina At Chapel Hill |
Viral adjuvants
|
WO2006068794A2
(en)
|
2004-11-22 |
2006-06-29 |
New York University |
Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof
|
US20060198854A1
(en)
*
|
2004-12-28 |
2006-09-07 |
Peter Pushko |
Vector platforms derived from the alphavirus vaccines
|
CA2594040A1
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
CA2595726A1
(en)
*
|
2005-01-26 |
2006-08-03 |
The Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
|
CA2597921A1
(en)
*
|
2005-02-15 |
2007-04-26 |
University Of North Carolina At Chapel Hill |
New live virus vaccines
|
JP2008531581A
(ja)
*
|
2005-02-23 |
2008-08-14 |
ユーエービー リサーチ ファウンデーション |
アルキル−グリコシドで増強されたワクチン接種
|
US20110223197A1
(en)
|
2005-10-18 |
2011-09-15 |
Novartis Vaccines And Diagnostics Inc. |
Mucosal and Systemic Immunization with Alphavirus Replicon Particles
|
WO2008024844A2
(en)
*
|
2006-08-22 |
2008-02-28 |
The Johns Hopkins University |
Anticancer combination therapies
|
CA2663298C
(en)
|
2006-09-12 |
2015-11-24 |
Alphavax, Inc. |
Alphavirus replicon particles as immunological adjuvants
|
AU2007296489B2
(en)
*
|
2006-09-12 |
2013-07-04 |
Alphavax, Inc. |
Alphavirus replicon particles matched to protein antigens as immunological adjuvants
|
WO2008058035A1
(en)
*
|
2006-11-03 |
2008-05-15 |
Alphavax, Inc. |
Alphavirus and alphavirus replicon particle formulations and methods
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
PL2183368T3
(pl)
|
2007-06-21 |
2016-12-30 |
|
Kasety bez promotora do ekspresji alfawirusowych białek strukturalnych
|
US20090162395A1
(en)
*
|
2007-09-26 |
2009-06-25 |
Crowe Jr James E |
Vaccine for rsv and mpv
|
WO2009048633A2
(en)
*
|
2007-10-11 |
2009-04-16 |
The Board Of Regents Of The University Of Texas System |
Chimeric chikungunya virus and uses thereof
|
LT2604695T
(lt)
|
2007-12-27 |
2022-12-12 |
Universität Zürich |
Replikacijos defektų turintys arenaviruso vektoriai
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
US20100040650A1
(en)
*
|
2008-05-30 |
2010-02-18 |
Crowe Jr James E |
Virus-Like paramyxovirus particles and vaccines
|
WO2009156155A1
(en)
*
|
2008-06-25 |
2009-12-30 |
Probiogen Ag |
Cell line for propagation of highly attenuated alphaviruses
|
US9296790B2
(en)
|
2008-10-03 |
2016-03-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for protein delivery
|
US8680258B2
(en)
|
2008-12-01 |
2014-03-25 |
Alphavax, Inc. |
Use of microRNAs to control virus helper nucleic acids
|
US20120128714A1
(en)
|
2009-04-08 |
2012-05-24 |
Wolchok Jedd D |
Alphavirus Replicon Particles Expressing TRP2
|
WO2011071574A2
(en)
*
|
2009-09-02 |
2011-06-16 |
United States Deparment Of The Army, As Represented By The Secretary Of The Army |
Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
|
EP2528941A4
(en)
*
|
2010-01-25 |
2013-05-29 |
Univ New York |
RECOMBINANT BOTULINUM NEUROTOXIN DERIVATIVES MODIFIED FOR TRAFFIC STUDIES AND NEURONAL DELIVERY
|
WO2012001196A2
(es)
|
2010-06-28 |
2012-01-05 |
Proyecto De Biomedicina Cima, S.L. |
Vectores alfavirales y usos de los mismos para la expresión de genes heterólogos
|
LT3243526T
(lt)
|
2010-07-06 |
2020-02-10 |
Glaxosmithkline Biologicals S.A. |
Rnr pristatymas, skirtas keleto imuninio atsako paleidimui
|
JP5940064B2
(ja)
|
2010-07-06 |
2016-06-29 |
ノバルティス アーゲー |
低用量のrnaを用いた大型哺乳動物の免疫化
|
WO2012006378A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Liposomes with lipids having an advantageous pka- value for rna delivery
|
US8198429B2
(en)
|
2010-08-09 |
2012-06-12 |
Avi Biopharma, Inc. |
Antisense antiviral compounds and methods for treating a filovirus infection
|
RS63983B1
(sr)
|
2010-08-31 |
2023-03-31 |
Glaxosmithkline Biologicals Sa |
Pegilovani lipozomi za isporuku rnk koja kodira imunogen
|
JP2013544504A
(ja)
|
2010-10-11 |
2013-12-19 |
ノバルティス アーゲー |
抗原送達プラットフォーム
|
US10004797B2
(en)
|
2010-10-27 |
2018-06-26 |
Harrisvaccines, Inc. |
Method of rapidly producing improved vaccines for animals
|
US20120107355A1
(en)
|
2010-10-27 |
2012-05-03 |
Harrisvaccines, Inc. |
Method of rapidly producing improved vaccines for animals
|
US8822427B2
(en)
|
2010-10-27 |
2014-09-02 |
Harrisvaccines |
Methods and compositions to protect aquatic invertebrates from disease
|
US20140093556A1
(en)
|
2011-01-28 |
2014-04-03 |
Sanofi Pasteur Sa |
Immunological Compositions Against HIV
|
EP3332802A1
(en)
|
2011-07-06 |
2018-06-13 |
GlaxoSmithKline Biologicals SA |
Immunogenic combination compositions and uses thereof
|
AU2013240248B2
(en)
|
2012-03-26 |
2018-12-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Delivery of packaged RNA to mammalian cells
|
BR112015009103A2
(pt)
|
2012-10-23 |
2017-07-04 |
Harrisvaccines Inc |
método para proteger um animal invertebrado aquático contra o vírus da mionecrose infecciosa (imnv), método para produzir um composição e composição
|
DK2948174T3
(da)
|
2013-01-28 |
2019-12-02 |
Univ New York |
Fremgangsmåder til behandling under anvendelse af atoksiske neurotoksinderivater
|
WO2014140938A2
(en)
|
2013-03-14 |
2014-09-18 |
Centre Hospitalier Universitaire Vaudois |
Immunological methods
|
US9809801B2
(en)
|
2013-03-15 |
2017-11-07 |
Université De Genève |
Anti-mycobacterial vaccines
|
US20160312242A1
(en)
|
2013-12-16 |
2016-10-27 |
The United States of America, as represented by the Secretary, Dep. of Health and Human Services |
Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon
|
WO2016094555A1
(en)
|
2014-12-09 |
2016-06-16 |
New York University |
Clostridial neurotoxin fusion proteins, propeptide fusions, their expression, and use
|
WO2017180770A1
(en)
|
2016-04-13 |
2017-10-19 |
Synthetic Genomics, Inc. |
Recombinant arterivirus replicon systems and uses thereof
|
WO2018035311A1
(en)
*
|
2016-08-19 |
2018-02-22 |
Gray John T |
Compositions and methods for modulating gene expression using reading frame surveillance
|
CN110073002B
(zh)
|
2016-10-17 |
2024-06-11 |
杨森制药公司 |
重组病毒复制子体系及其用途
|
KR102655641B1
(ko)
|
2016-12-05 |
2024-04-05 |
얀센 파마슈티칼즈, 인코포레이티드 |
유전자 발현을 향상시키기 위한 조성물 및 방법
|
JP2020518648A
(ja)
|
2017-05-08 |
2020-06-25 |
グリットストーン オンコロジー インコーポレイテッド |
アルファウイルス新生抗原ベクター
|
EA202091517A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и устройство для доставки вакцин против вируса гепатита b (hbv)
|
EA202091516A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
|
EA202091513A1
(ru)
|
2017-12-19 |
2020-09-09 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Вакцины против вируса гепатита b (hbv) и их применение
|
US20190185822A1
(en)
*
|
2017-12-20 |
2019-06-20 |
Vlp Therapeutics, Llc |
Alphavirus replicon particle
|
EP3740245A4
(en)
|
2018-01-19 |
2022-01-05 |
Janssen Pharmaceuticals, Inc. |
INDUCTION AND ENHANCEMENT OF IMMUNE RESPONSES USING RECOMBINATION REPLICON SYSTEMS
|
TW202000907A
(zh)
*
|
2018-05-23 |
2020-01-01 |
美商葛利史東腫瘤科技公司 |
共有抗原
|
WO2020243719A1
(en)
|
2019-05-30 |
2020-12-03 |
Gritstone Oncology, Inc. |
Modified adenoviruses
|
US20220313815A1
(en)
|
2019-06-20 |
2022-10-06 |
Janssen Sciences Ireland Unlimited Company |
Self-replicating rna molecules for hepatitis b virus (hbv) vaccines and uses thereof
|
WO2021255225A1
(en)
*
|
2020-06-19 |
2021-12-23 |
Intervet International B.V. |
Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus
|
JP2023530135A
(ja)
*
|
2020-06-19 |
2023-07-13 |
インターベット インターナショナル ベー. フェー. |
特定のウイルス系統の抗原をエンコードする核酸構築物を含むブタインフルエンザaウイルスワクチン
|
AU2021320896A1
(en)
|
2020-08-06 |
2023-03-23 |
Gritstone Bio, Inc. |
Multiepitope vaccine cassettes
|
WO2023225637A1
(en)
|
2022-05-19 |
2023-11-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Replicating rna vaccine for crimean-congo hemorrhagic fever virus
|
WO2024149832A1
(en)
|
2023-01-12 |
2024-07-18 |
Bavarian Nordic A/S |
RECOMBINANT MODIFIED saRNA (VRP) FOR CANCER VACCINE
|